ATAI Life Sciences
Venture Capital
German biopharmaceutical company founded 2018 that develops psychedelic-based medicines for psychiatric conditions via a portfolio of subsidiary companies.
Berlin, Germany · 3+ investments
Early Stage
Growth
Biotech
Mental Health
Psychedelics
- Headquarters
- Berlin, Germany
- Founded
- 2018
- Website
- atai.life
- Total Investments
- 3
- Last Investment
- Nov 2025
- Geographic Focus
- Global
Investment Thesis
Acquires and incubates psychedelic medicine companies targeting treatment-resistant psychiatric conditions including depression and PTSD.
ATAI Life Sciences is a Venture Capital firm based in Berlin, Germany. It has made 3 investments in Biotech and Mental Health.
Investment History
Sign up to view investment history
Create a free account — 10 credits a month to unlock deal history, amounts, and round details.